IMV Inc. (IMVIF)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 31.33 Million USD | -37.4% |
| 2021 | 50.05 Million USD | 8.82% |
| 2020 | 45.99 Million CAD | 165.88% |
| 2019 | 17.3 Million CAD | 3.07% |
| 2018 | 16.78 Million USD | 23.48% |
| 2017 | 13.59 Million USD | 20.72% |
| 2016 | 11.26 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 Q3 | 32.04 Million USD | -21.0% |
| 2022 FY | 31.33 Million USD | -37.4% |
| 2022 Q2 | 40.55 Million USD | -0.5% |
| 2022 Q4 | 31.33 Million USD | -2.21% |
| 2022 Q1 | 40.76 Million USD | -18.56% |
| 2021 Q3 | 49.49 Million USD | 0.0% |
| 2021 Q4 | 50.05 Million USD | 1.14% |
| 2021 FY | 50.05 Million USD | 8.82% |
| 2020 FY | 45.99 Million CAD | 165.88% |
| 2019 FY | 17.3 Million CAD | 3.07% |
| 2018 FY | 16.78 Million USD | 23.48% |
| 2017 FY | 13.59 Million USD | 20.72% |
| 2016 FY | 11.26 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -1356340.996% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -1500.141% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -196.89% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -5575.177% |
| Rebus Holdings, Inc. | 5000.00 USD | -626575.74% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 75.936% |
| Qrons Inc. | 420.00 USD | -7460325.476% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -3965.922% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -12.131% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -6420.306% |
| Skye Bioscience, Inc. | 11.94 Million USD | -162.418% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 19.341% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -334.0% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -40937.519% |
| SQZ Biotechnologies Company | 107.18 Million USD | 70.767% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -2088.065% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -43199.643% |
| Mesoblast Limited | 667.9 Million USD | 95.309% |
| Marizyme, Inc. | 22.01 Million USD | -42.329% |
| Genus plc | 1.02 Billion USD | 96.955% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -2206.748% |
| Pharming Group N.V. | 462.85 Million USD | 93.23% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -845.779% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -6178.825% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -4897.414% |
| ContraFect Corporation | 20.67 Million USD | -51.525% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -7926.772% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -8098.763% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -655.755% |
| MultiCell Technologies, Inc. | 126.22 USD | -24824640.136% |
| ONE Bio Corp. | 70.08 Million USD | 55.292% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -3234.485% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 75.618% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -7157.996% |
| Q BioMed Inc. | 3.51 Million USD | -791.3% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 10.93% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -11892.555% |
| Biomind Labs Inc. | 73.81 Thousand USD | -42346.778% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 92.979% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -2062.676% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -4.394% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -1040.931% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -4457.735% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -1103.666% |
| GB Sciences, Inc. | 103.44 Thousand USD | -30191.165% |
| Alpha Cognition Inc. | 2.45 Million USD | -1177.798% |
| HST Global, Inc. | 1526.00 USD | -2053228.113% |
| CSL Limited | 38.02 Billion USD | 99.918% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -3071.542% |
| Halberd Corporation | 10.13 Thousand USD | -309186.221% |
| Enzolytics Inc. | 361.7 Million USD | 91.337% |
| Agentix Corp. | 261.39 Thousand USD | -11887.278% |
| Resverlogix Corp. | 8.11 Million USD | -286.122% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1568.572% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.31% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 34.313% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -4798.537% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -137443.51% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -250.131% |
| AVAX Technologies, Inc. | 7.37 Million USD | -324.741% |
| Zenith Capital Corp. | 7410.00 USD | -422758.124% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.075% |
| Ember Therapeutics, Inc. | 184.00 USD | -17029132.065% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -9636.856% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -11888.563% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -3276.628% |
| Kadimastem Ltd | 2.3 Million USD | -1259.926% |
| Helix BioMedix, Inc. | 3.02 Million USD | -935.798% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 40.544% |
| BioStem Technologies, Inc. | 14.56 Million USD | -115.2% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -54781.051% |
| LadRx Corporation | 2.3 Million USD | -1257.686% |
| Cell Source, Inc. | 195.17 Thousand USD | -15954.53% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -8760.939% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -8760.939% |
| NovAccess Global Inc. | 62.24 Thousand USD | -50237.018% |
| Affymax, Inc. | 7.44 Million USD | -320.983% |
| Itoco Inc. | 1.4 Million USD | -2138.013% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -32656.397% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -29460.176% |
| Mobile Lads Corp. | 52.00 USD | -60257182.692% |
| CytoDyn Inc. | 11.13 Million USD | -181.374% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -21816.03% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -175144.894% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -8028.702% |
| SYBLEU INC | 330.46 Thousand USD | -9381.64% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -7553.176% |
| International Stem Cell Corporation | 5.39 Million USD | -481.332% |
| Bioxytran, Inc. | 137.63 Thousand USD | -22665.361% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -108.866% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -88.997% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -39563.022% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -3523.756% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -316.839% |
| Neutra Corp. | 2851.00 USD | -1098945.493% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 3.309% |
| PureTech Health plc | 693.97 Million USD | 95.485% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -288.223% |
| IXICO plc | 15.84 Million USD | -97.766% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -278.336% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 69.674% |
| CSL Limited | 38.02 Billion USD | 99.918% |
| Cellectis S.A. | 333.99 Million USD | 90.618% |